CCDC22
Basic information
Region (hg38): X:49235470-49250520
Previous symbols: [ "CXorf37" ]
Links
Phenotypes
GenCC
Source:
- Ritscher-Schinzel syndrome 2 (Limited), mode of inheritance: XL
- Ritscher-Schinzel syndrome (Supportive), mode of inheritance: AR
- Ritscher-Schinzel syndrome 2 (Moderate), mode of inheritance: XL
- Ritscher-Schinzel syndrome 2 (Strong), mode of inheritance: XL
- Ritscher-Schinzel syndrome 2 (Strong), mode of inheritance: XL
- Ritscher-Schinzel syndrome 2 (Limited), mode of inheritance: XL
- epilepsy (Limited), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ritscher-Schinzel syndrome 2 | XL | Cardiovascular | Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management | Cardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic | 21826058; 24916641 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (92 variants)
- not_provided (90 variants)
- Ritscher-Schinzel_syndrome_2 (38 variants)
- CCDC22-related_disorder (13 variants)
- Intellectual_disability (7 variants)
- Ritscher-Schinzel_syndrome_1 (2 variants)
- Obesity (1 variants)
- Familial_thoracic_aortic_aneurysm_and_aortic_dissection (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCDC22 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014008.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 25 | ||||
missense | 122 | 26 | 155 | |||
nonsense | 0 | |||||
start loss | 1 | 1 | ||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 2 | 2 | 126 | 48 | 4 |
Highest pathogenic variant AF is 9.11575e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCDC22 | protein_coding | protein_coding | ENST00000376227 | 17 | 15061 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000209 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.29 | 211 | 271 | 0.779 | 0.0000244 | 3966 |
Missense in Polyphen | 49 | 98.817 | 0.49587 | 1523 | ||
Synonymous | -0.0883 | 109 | 108 | 1.01 | 0.00000880 | 1337 |
Loss of Function | 4.56 | 0 | 24.2 | 0.00 | 0.00000182 | 386 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in regulation of NF-kappa-B signaling. Promotes ubiquitination of I-kappa-B-kinase subunit IKBKB and its subsequent proteasomal degradation leading to NF-kappa-B activation; the function may involve association with COMMD8 and a CUL1-dependent E3 ubiquitin ligase complex. May down-regulate NF- kappa-B activity via association with COMMD1 and involving a CUL2- dependent E3 ubiquitin ligase complex. Regulates the cellular localization of COMM domain-containing proteins, such as COMMD1 and COMMD10 (PubMed:23563313). Plays a role in copper ion homeostasis. Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes (PubMed:25355947). {ECO:0000269|PubMed:23563313, ECO:0000269|PubMed:25355947}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- loftool
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.68
Haploinsufficiency Scores
- pHI
- 0.0912
- hipred
- N
- hipred_score
- 0.469
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccdc22
- Phenotype
Gene ontology
- Biological process
- cellular copper ion homeostasis;Golgi to plasma membrane transport;cytoplasmic sequestering of NF-kappaB;protein transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;post-translational protein modification;positive regulation of ubiquitin-dependent protein catabolic process
- Cellular component
- cellular_component;nucleoplasm;endosome;cytosol
- Molecular function
- protein binding;cullin family protein binding